A Dose Ranging Study of the Effects of Macroflux PTH Compared With Macroflux Placebo and FORTEO in Postmenopausal Women With Osteoporosis

Trial Profile

A Dose Ranging Study of the Effects of Macroflux PTH Compared With Macroflux Placebo and FORTEO in Postmenopausal Women With Osteoporosis

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Aug 2017

At a glance

  • Drugs Teriparatide; Teriparatide
  • Indications Menopause; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Sponsors Zosano Pharma
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 01 Jan 2010 Results published in Journal of Clinical Endocrinology and Metabolism.
    • 10 Nov 2009 Primary endpoint 'Lumbar spine bone mineral density' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top